Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.

Abstract excerpt

No drug therapy is completely risk free, and the costs associated with non-response and adverse effects can exceed the cost of the therapy. The ultimate goal of pharmacogenetic research is to find robust genetic predictors of drug response that enable the development of prospective genetic tests to reliably identify patients at risk of non-response or of developing an adverse effect prior to the drug being...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Azathioprine
• Share to Biotransformation
• Share to Drug Hypersensitivity